Abstract:Shan Li, 1, &ast Fengdi Zhang, 2, &ast Ritian Lin, 1 Qinjuan Sun, 1 Lihong Qu, 2 Lan Zhong 1 1 Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China; 2 Department of Infectious Diseases, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lan Zhong, Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, 150, Jimo Road, Pudong New Area, Shanghai, 200120, People's Republic of China, Email Lihong Qu, Department of Infectious Diseases, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China, Email Purpose: The rapid global spread of the SARS-CoV-2 Omicron variant introduces a novel complication: the emergence of IBD (inflammatory bowel disease)-like ulcers in certain patients. This research delves into this new challenge by juxtaposing the clinical manifestations and genetic expression patterns of individuals affected by the Omicron variant of COVID-19 with those diagnosed with IBD. It aims to decode the link between these conditions, potentially shedding light on previously unexplored facets of COVID-19 pathophysiology. This investigation emphasizes gene expression analysis as a key tool to identify wider disease correlations and innovative therapeutic avenues. Patients and Methods: From March to December 2022, patients with SARS-CoV-2 Omicron infection and inflammatory bowel disease and healthy controls were recruited in Shanghai East Hospital, Shanghai, China. The epidemiological and clinical characteristics of the patients were compared. Four RNA sequencing datasets (GSE205244, GSE201530, GSE174159, and GSE186507) were extracted from the Gene Expression Omnibus database to detect mutually differentially expressed genes and common pathways in patients with SARS-CoV-2 infection and inflammatory bowel disease. Results: Compared to patients with active inflammatory bowel disease, patients with SARS-CoV-2 infection were more likely to have elevated interferon-α levels and an increased lymphocyte count and less likely to have high interleukin-6, tumor necrosis factor-α, and C-reactive protein levels and an elevated neutrophil count. A total of 51 common differentially expressed genes were identified in the four RNA-sequencing datasets. Enrichment analysis suggested that these genes were related to inflammation and the immune response, especially the innate immune response and nucleotide oligomerization domain-like receptor signaling pathway. Conclusion: The inflammation and immune-response pathways in COVID-19 and inflammatory bowel disease have several similarities and some differences. The study identifies the NLR signaling pathway's key role in both COVID-19 and IBD, suggesting its potential as a target for therapeutic intervention and vaccine development. Keywords: viral-induced inflammation, omicron infection, RNA sequencing, gene expression in infection, inflammatory bowel disease Coronavirus disease 2019 (COVID-19) is a highly contagious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread worldwide rapidly over the past 4 years. 1 After infection with SARS-CoV-2, some patients have been reported to develop long-term symptoms or health problems, a phenomenon known as Long-COVID. 2 Long COVID, impacting at least 10% of individuals infected by SARS-CoV-2, presents a compelling case for further investigation due to its extensive symptomatology affecting multiple organ systems. Gastrointestinal symptoms of Long COVID are associated with persistent SARS-CoV-2 replication in the intestinal mucosa, including nausea, abdominal pain, loss of appetite, and constipation, with significant changes in the composition of the gut microbiota. 3,4 Interestingly, during the COVID-19 epidemic in Shanghai, some patients who underwent colonoscopy for gastrointestinal symptoms following COVID-19 were found to have inflammatory bowel disease (IBD)-like ulcers. Similar cases have also been reported by other researchers. 5 IBD is a group of heterogenous, chronic, non-specific intestinal inflammatory diseases with elusive etiology and pathogenesis, clinically classified as Crohn's disease (CD) and ulcerative colitis (UC). UC is confined to the colon and can lead to ulceration, severe bleeding, toxic megacolon, and fulminant colitis. 6 CD can involve any part of the digestive tract and is characterized by transmural inflammation that can lead to complicati -Abstract Truncated-

Multi-ancestry GWAS of diarrhea during acute SARS-CoV2 infection identifies multiple novel loci and contrasting etiological roles of irritable bowel syndrome subtypes

Shared genetic architecture between COVID-19 and irritable bowel syndrome: a large-scale genome-wide cross-trait analysis

Unraveling the Genetic Susceptibility of Irritable Bowel Syndrome: integrative genome-wide analyses in 845,492 individuals: a diagnostic study

Genetic support of the causal association between gut microbiome and COVID-19: a bidirectional Mendelian randomization study

‭Multi-ancestry GWAS of Long COVID identifies‬ ‭immune-related loci and etiological links to chronic fatigue‬ syndrome, fibromyalgia and depression‬ ‭

The causal links between gut microbiota and COVID‐19: A Mendelian randomization study

Causal effects of the gut microbiome on COVID-19 susceptibility and severity: a two-sample Mendelian randomization study

OP08 Multi-ancestry genome-wide association study of inflammatory bowel disease identifies 125 novel loci and directly implicates new genes in disease susceptibility

The causal role of gut microbiota in susceptibility of Long COVID: a Mendelian randomization study

Genome-wide association study of COVID-19 severity among the Chinese population

Large-scale genetic correlation studies explore the causal relationship and potential mechanism between gut microbiota and COVID-19-associated risks

Trans-ancestry, Bayesian meta-analysis discovers 20 novel risk loci for inflammatory bowel disease in an African American, East Asian and European cohort

Genome-wide association studies of COVID-19: Connecting the dots

Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries

Trans-ethnic genome-wide association study of severe COVID-19

Shared Immune Associations Between COVID-19 and Inflammatory Bowel Disease: A Cross-Sectional Observational Study in Shanghai, China

GWAS-Identified Loci are Associated with Obesity and Type 2 Diabetes Mellitus in Patients with Severe COVID-19

Shared Genetic Susceptibilities for Irritable Bowel Syndrome and Depressive Disorder in Chinese Patients Uncovered by Pooled Whole-Exome Sequencing

Genome-wide association study of COVID-19 Breakthrough Infections and genetic overlap with other diseases: A study of the UK Biobank

Novel risk loci for COVID-19 hospitalization among admixed American populations

Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects